These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11857608)

  • 1. Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation.
    Souka AP; Krampl E; Geerts L; Nicolaides KH
    Prenat Diagn; 2002 Feb; 22(2):91-2. PubMed ID: 11857608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
    Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution of nuchal translucency at 10-13 weeks of pregnancy.
    Schuchter K; Wald N; Hackshaw AK; Hafner E; Liebhart E
    Prenat Diagn; 1998 Mar; 18(3):281-6. PubMed ID: 9556045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuchal translucency in the first trimester of pregnancy: ten years on and still a pain in the neck?
    Ville Y
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):5-8. PubMed ID: 11489217
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased nuchal translucency as a prenatal manifestation of congenital adrenal hyperplasia.
    Masturzo B; Hyett JA; Kalache KD; Rumsby G; Jauniaux E; Rodeck CH
    Prenat Diagn; 2001 Apr; 21(4):314-6. PubMed ID: 11288125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester.
    Whitlow BJ; Economides DL
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):258-61. PubMed ID: 9618848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome.
    Sebire NJ; D'Ercole C; Hughes K; Carvalho M; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Aug; 10(2):86-9. PubMed ID: 9286014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital nephrotic syndrome presenting with increased nuchal translucency in the first trimester.
    Souka AP; Skentou H; Geerts L; Bower S; Nicolaides KH
    Prenat Diagn; 2002 Feb; 22(2):93-5. PubMed ID: 11857609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
    Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
    Chasen ST; Sharma G; Kalish RB; Chervenak FA
    Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blackfan-Diamond anemia and dyserythropoietic anemia presenting with increased nuchal translucency at 12 weeks of gestation.
    Souka AP; Bower S; Geerts L; Huggon I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2002 Aug; 20(2):197-9. PubMed ID: 12153674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal congenital arthrogryposis presents with increased nuchal translucency at 10-14 weeks of gestation.
    Hyett J; Noble P; Sebire NJ; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 May; 9(5):310-3. PubMed ID: 9201873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuchal translucency in normal fetuses in a Thai population.
    Panburana P; Jaovisidh A; Ajjimakorn S; Tungkajiwangoon P
    J Med Assoc Thai; 2002 Feb; 85(2):245-9. PubMed ID: 12081126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuchal translucency and gestational age.
    Wald N; Rodeck C; Rudnicka A; Hackshaw A
    Prenat Diagn; 2004 Feb; 24(2):150-1. PubMed ID: 14974125
    [No Abstract]   [Full Text] [Related]  

  • 19. Prenatal diagnosis of Milroy's primary congenital lymphedema.
    Makhoul IR; Sujov P; Ghanem N; Bronshtein M
    Prenat Diagn; 2002 Sep; 22(9):823-6. PubMed ID: 12224079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal nuchal translucency: a need to understand the physiological basis.
    Moscoso G
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):6-8. PubMed ID: 7850594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.